
Please try another search
Syncom Formulations (India) Limited manufactures, markets, and sells pharmaceutical formulation products in India and internationally. It operates through Manufacturing and Dealing in Pharmaceutical Drug and Formulations, Trading of Commodities, and Renting of Properties segments. The company offers antibiotics/antiinfectives, anthelmintics, antimalarial, cardiac, derma, gastro, dry syrups and suspensions, creams, gel, ORS, jelly, gynae, inhalers, opthal, ortho, and pediatrics formulations in dosage forms. It also provides life care, evolve, and the right nutrition products under the Cratus brand. In addition, the company offers its pharmaceutical formulation products in various dosage forms, such as tablets, capsules, ointments, injections, liquids orals, and effervescent. Syncom Formulations (India) Limited was incorporated in 1988 and is based in Indore, India.
Name | Age | Since | Title |
---|---|---|---|
Vinod Kumar Kabra | 72 | 2007 | Independent Non-Executive Director |
Vijay Shankarlal Bankda | 67 | 1999 | MD and Executive & Non Independent Director |
Kedarmal Shankarlal Bankda | 73 | 1992 | Whole-Time Director |
Ankit Jain | 38 | 2023 | Non-Executive Independent Director |
Ankit Kedarmal Bankda | 39 | 2014 | Executive Chairman |
Ruchi Jindal | 35 | 2022 | Non-Executive Independent Woman Director |
Ritesh Kumar Lunkad | 50 | 2023 | Non-Executive Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review